FDA Inspection 1158004 — HonorBridge
The FDA completed an inspection of HonorBridge on December 2, 2021 in Winston Salem, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 2, 2021
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Winston Salem, NC (United States)